Cumulative detection and clinical outcomes of ampullary tumors in patients with familial adenomatous polyposis undergoing endoscopic surveillance
Abstract Background Patients with familial adenomatous polyposis (FAP) are at an increased risk of ampullary tumors. This study aimed to evaluate their cumulative detection rate and clinical outcomes. Methods We retrospectively identified consecutive patients with FAP who first visited our hospital in 2007–2023 without a known ampullary tumor. The primary outcome was the cumulative detection of ampullary tumors. The secondary outcomes included the therapeutic outcomes of endoscopic papillectomy (EP) and clinical course of ampullary tumors managed by watchful waiting. Results Among 124 patients with FAP, ampullary tumors were found in 33 (pTis-T1a adenocarcinoma, n = 5; adenoma, n = 28). The median lesion size was significantly larger in the adenocarcinoma group than in the adenoma group (25 mm vs. 10 mm; p = 0.001). The cumulative detection of ampullary tumors linearly increased with age, reaching 33% by 50 years, and was significantly higher in patients with Spigelman stage II–IV disease than in those with stage 0–I ( p = 0.003). EP was performed after the initial detection in 19 patients; 14 patients underwent watchful waiting. 2 (14%) of these subsequently required EP due to lesion growth. Thus, 21 patients underwent EP. Adverse events of EP included pancreatitis (14%), delayed bleeding (38%), and intraprocedural bleeding (5%). Local recurrence occurred in 38%. Conclusions Careful ampullary evaluation is required in older patients with FAP and those with an advanced Spigelman stage. EP was a reasonable therapeutic option, although adverse events and local recurrence require attention. Watchful waiting might be considered under appropriate surveillance.
Authors
- Shunsuke Yoshii (ORCID: https://orcid.org/0000-0002-7817-1809)
- Yugo Kai (ORCID: https://orcid.org/0000-0003-3749-1360)
- Noriya Uedo (ORCID: https://orcid.org/0000-0002-3029-9272)
- Takashi Kanesaka (ORCID: https://orcid.org/0000-0002-8197-2295)
- Hitoshi Yoshiji (ORCID: https://orcid.org/0000-0002-5243-8544)
- Yasuhiro Tani (ORCID: https://orcid.org/0000-0003-4830-628X)
- Minoru Shigekawa (ORCID: https://orcid.org/0009-0006-9295-3651)
- Ryu Ishihara (ORCID: https://orcid.org/0000-0002-8796-718X)
- Ryoji Takada (ORCID: https://orcid.org/0000-0002-6568-8091)
- Sachiko Yamamoto (ORCID: https://orcid.org/0000-0003-2257-5270)
- Satoki Shichijo (ORCID: https://orcid.org/0000-0002-5750-0976)
- Tomoki Michida
- Hitoshi Mori (ORCID: https://orcid.org/0009-0007-5574-2545)
- Koji Higashino
- Yoshimi Tanaka
- Minoru Kato
Institutions
- Osaka International Cancer Institute (JP)
- Nara Medical University (JP)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-12
- DOI
- https://doi.org/10.21203/rs.3.rs-11535485/v1
- Primary Topic
- Genetic factors in colorectal cancer
- Type
- preprint